Zobrazeno 1 - 10
of 20
pro vyhledávání: '"O. W. Bjerrum"'
Publikováno v:
Vox sanguinis. 113(2)
BACKGROUND AND OBJECTIVES Despite the obligate iron loss from blood donation, some donors present with hyperferritinaemia that can result from a wide range of acute and chronic conditions including hereditary haemochromatosis (HH). The objective of o
Publikováno v:
Vox sanguinis. 104(2)
The literature contains little on the prevalence and causes of high predonation haemoglobin levels among blood donors. This study aimed to characterize and develop an algorithm to manage would-be donors with polycythaemia.Between November 2009 and No
Autor:
O W Bjerrum, Dirk Roos, T Mühlebach, Bernd H. Belohradsky, N Borregard, Ron S. Weening, M de Boer, Reinhard Seger, N H Valerius
Publikováno v:
Journal of Leukocyte Biology. 51:164-171
Five male patients from four different families presented with a clinical record of chronic granulomatous disease (CGD): recurrent infections of the skin and/or respiratory tract with catalase-positive microorganisms, sometimes in combination with gr
Autor:
N. Borregaard, O. W. Bjerrum
Publikováno v:
Scandinavian Journal of Immunology. 31:305-313
This study introduces a simple, reproducible assay for HLA class I antigen using antibodies against beta 2-microglobulin and the heavy chain on HLA. The sandwich technique was named mixed enzyme-linked immunosorbent assay (MELISA), and was designed f
Publikováno v:
Ugeskrift for laeger. 163(9)
Primary cardiac non-Hodgkin lymphoma is very rare. Results recently published suggest that the prognosis is good, if the lymphoma is diagnosed early. The symptoms are nevertheless unspecific and a clinical investigation is often inconclusive. We repo
Publikováno v:
Clinical and laboratory haematology. 17(3)
The serum concentration of the N-terminal peptide of type III procollagen (PIIINP) was determined in 32 patients with myelomatosis (MM). Four subjects were studied at the time of diagnosis and the remaining patients at variable intervals from diagnos
Autor:
N, Keldsen, O W, Bjerrum, I M, Dahl, A, Drivsholm, J, Ellegaard, O, Gadeberg, P, Gimsing, T, Grønvold, M M, Hansen, E, Hippe
Publikováno v:
European journal of haematology. 51(2)
One-hundred-and-fifty-one patients with previously untreated multiple myeloma were allocated to treatment with either NOP regimen (mitoxantrone 16 mg/m2 and vincristine 2 mg day 1 and prednisolone 250 mg day 1-4 and 17-20) or M+P regimen (melphalan 0
Autor:
O W, Bjerrum
Publikováno v:
Danish medical bulletin. 40(2)
Neutrophil granulocytes are the most important white blood cells in the combat of non-viral infections. Circumstantial evidence indicates that neutrophils in addition modulate the inflammatory process. Production of neutrophils takes place in the bon
Autor:
P, Gimsing, O W, Bjerrum, E, Brandt, J, Ellegaard, S A, Evensen, M M, Hansen, M, Hedenus, E, Hippe, N, Keldsen, I, Palva
Publikováno v:
British journal of haematology. 77(1)
In a phase II study, patients with refractory myelomatosis were treated with a combination chemotherapy (NOP regimen): mitoxantrone (bolus injection of 4 mg/m2 on days 1-4), vincristine (continuous infusion of 0.4 mg/24 h on days 1-4) and prednisone
Publikováno v:
Scandinavian journal of immunology. 32(3)
Beta-2 microglobulin (beta 2m) constitutes the light invariant chain of HLA class I antigen, and is a constituent of mobilizable compartments of neutrophils. Two forms of beta 2m exist: native beta 2m and proteolytically modified beta 2m (Des-Lys58-b